Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)
Primary Purpose
Hypertension
Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
Nebivolol
Placebo
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension focused on measuring Stage 1, Stage 2, Hypertension
Eligibility Criteria
Inclusion Criteria:
- Male and female outpatients, of age 18 - 54 years
- Patients diagnosed with stage 1 or stage 2 essential hypertension
- Normal physical examination findings and electrocardiogram (ECG) results or abnormal findings judged by the Investigator to be not clinically significant
Exclusion Criteria:
- Secondary hypertension or severe hypertension
- History of Type 1 diabetes mellitus
- A medical contraindication to discontinuing a current antihypertensive therapy
- Clinically significant respiratory disease that prohibit use of a beta blocker
Sites / Locations
- Forest Investigative Site 065
- Forest Investigative Site 067
- Forest Investigative Site 070
- Forest Investigative Site 049
- Forest Investigative Site 034
- Forest Investigative Site 039
- Forest Investigative Site 024
- Forest Investigative Site 020
- Forest Investigative Site 021
- Forest Investigative Site 040
- Forest Investigative Site 047
- Forest Investigative Site 073
- Forest Investigative Site 077
- Forest Investigative Site 060
- Forest Investigative Site 054
- Forest Investigative Site 018
- Forest Investigative Site 028
- Forest Investigative Site 059
- Forest Investigative Site 033
- Forest Investigative Site 006
- Forest Investigative Site 044
- Forest Investigative Site 001
- Forest Investigative Site 012
- Forest Investigative Site 032
- Forest Investigative Site 055
- Forest Investigative Site 045
- Forest Investigative Site 031
- Forest Investigative Site 009
- Forest Investigative Site 007
- Forest Investigative Site 004
- Forest Investigative Site 072
- Forest Investigative Site 069
- Forest Investigative Site 025
- Forest Investigative Site 029
- Forest Investigative Site 068
- Forest Investigative Site 061
- Forest Investigative Site 057
- Forest Investigative Site 058
- Forest Investigative Site 008
- Forest Investigative Site 062
- Forest Investigative Site 075
- Forest Investigative Site 019
- Forest Investigative Site 017
- Forest Investigative Site 038
- Forest Investigative Site 035
- Forest Investigative Site 023
- Forest Investigative Site 048
- Forest Investigative Site 052
- Forest Investigative Site 014
- Forest Investigative Site 051
- Forest Investigative Site 003
- Forest Investigative Site 010
- Forest Investigative Site 011
- Forest Investigative Site 016
- Forest Investigative Site 005
- Forest Investigative Site 036
- Forest Investigative Site 002
- Forest Investigative Site 050
- Forest Investigative Site 030
- Forest Investigative Site 056
- Forest Investigative Site 022
- Forest Investigative Site 053
- Forest Investigative Site 066
- Forest Investigative Site 076
- Forest Investigative Site 037
- Forest Investigative Site 043
- Forest Investigative Site 015
- Forest Investigative Site 026
- Forest Investigative Site 027
- Forest Investigative Site 074
- Forest Investigative Site 071
- Forest Investigative Site 042
- Forest Investigative Site 063
- Forest Investigative Site 064
- Forest Investigative Site 046
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
1
2
Arm Description
Nebivolol (non-trade 5, 10 or 20 mg tablet), oral administration
Dose-matched placebo
Outcomes
Primary Outcome Measures
Trough Seated Diastolic Blood Pressure (DBP)
Change from baseline in mean seated trough cuff Diastolic Blood Pressure (DBP) at Week 8 as measured by an Omron device. The primary efficacy analysis was based on the Intent to Treat (ITT) population using a Last Observation Carried Forward (LOCF) approach.
Secondary Outcome Measures
Trough Seated Systolic Blood Pressure (SBP)
Change from baseline in mean seated trough cuff Systolic Blood Pressure (SBP) at Week 8 as measured by an Omron device. The secondary efficacy analysis was based on the Intent to Treat (ITT) population using a Last Observation Carried Forward (LOCF) approach.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01415531
Brief Title
Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)
Official Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years) Who Have Stage 1 or 2 Essential Hypertension
Study Type
Interventional
2. Study Status
Record Verification Date
March 2013
Overall Recruitment Status
Completed
Study Start Date
August 2011 (undefined)
Primary Completion Date
March 2012 (Actual)
Study Completion Date
April 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Forest Laboratories
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to assess the efficacy, safety, and tolerability of 8 weeks of therapy with nebivolol in comparison to placebo in younger patients 18 - 54 years of age with stage 1 or stage 2 essential hypertension.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Stage 1, Stage 2, Hypertension
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
641 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Experimental
Arm Description
Nebivolol (non-trade 5, 10 or 20 mg tablet), oral administration
Arm Title
2
Arm Type
Placebo Comparator
Arm Description
Dose-matched placebo
Intervention Type
Drug
Intervention Name(s)
Nebivolol
Intervention Description
Nebivolol (non-trade 5, 10 or 20 mg tablet), oral administration
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Dose-match placebo
Primary Outcome Measure Information:
Title
Trough Seated Diastolic Blood Pressure (DBP)
Description
Change from baseline in mean seated trough cuff Diastolic Blood Pressure (DBP) at Week 8 as measured by an Omron device. The primary efficacy analysis was based on the Intent to Treat (ITT) population using a Last Observation Carried Forward (LOCF) approach.
Time Frame
Change from Baseline to Week 8
Secondary Outcome Measure Information:
Title
Trough Seated Systolic Blood Pressure (SBP)
Description
Change from baseline in mean seated trough cuff Systolic Blood Pressure (SBP) at Week 8 as measured by an Omron device. The secondary efficacy analysis was based on the Intent to Treat (ITT) population using a Last Observation Carried Forward (LOCF) approach.
Time Frame
Change from Baseline to Week 8
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
54 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male and female outpatients, of age 18 - 54 years
Patients diagnosed with stage 1 or stage 2 essential hypertension
Normal physical examination findings and electrocardiogram (ECG) results or abnormal findings judged by the Investigator to be not clinically significant
Exclusion Criteria:
Secondary hypertension or severe hypertension
History of Type 1 diabetes mellitus
A medical contraindication to discontinuing a current antihypertensive therapy
Clinically significant respiratory disease that prohibit use of a beta blocker
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Tatjana Lukic, MD, M. Sc.
Organizational Affiliation
Forest Laboratories
Official's Role
Study Director
Facility Information:
Facility Name
Forest Investigative Site 065
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85014
Country
United States
Facility Name
Forest Investigative Site 067
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85014
Country
United States
Facility Name
Forest Investigative Site 070
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85014
Country
United States
Facility Name
Forest Investigative Site 049
City
Buena Park
State/Province
California
ZIP/Postal Code
90620
Country
United States
Facility Name
Forest Investigative Site 034
City
Burbank
State/Province
California
ZIP/Postal Code
91505
Country
United States
Facility Name
Forest Investigative Site 039
City
Costa Mesa
State/Province
California
ZIP/Postal Code
92626
Country
United States
Facility Name
Forest Investigative Site 024
City
Fountain Valley
State/Province
California
ZIP/Postal Code
92708
Country
United States
Facility Name
Forest Investigative Site 020
City
Fresno
State/Province
California
ZIP/Postal Code
93726
Country
United States
Facility Name
Forest Investigative Site 021
City
Fresno
State/Province
California
ZIP/Postal Code
93726
Country
United States
Facility Name
Forest Investigative Site 040
City
Greenbrae
State/Province
California
ZIP/Postal Code
94904
Country
United States
Facility Name
Forest Investigative Site 047
City
La Mesa
State/Province
California
ZIP/Postal Code
91942
Country
United States
Facility Name
Forest Investigative Site 073
City
Los Angeles
State/Province
California
ZIP/Postal Code
90057
Country
United States
Facility Name
Forest Investigative Site 077
City
Roseville
State/Province
California
ZIP/Postal Code
95661
Country
United States
Facility Name
Forest Investigative Site 060
City
San Bernardino
State/Province
California
ZIP/Postal Code
92404
Country
United States
Facility Name
Forest Investigative Site 054
City
San Francisco
State/Province
California
ZIP/Postal Code
94115
Country
United States
Facility Name
Forest Investigative Site 018
City
Spring Valley
State/Province
California
ZIP/Postal Code
91978
Country
United States
Facility Name
Forest Investigative Site 028
City
Denver
State/Province
Colorado
ZIP/Postal Code
80220
Country
United States
Facility Name
Forest Investigative Site 059
City
Brooksville
State/Province
Florida
ZIP/Postal Code
34601
Country
United States
Facility Name
Forest Investigative Site 033
City
Ft. Lauderdale
State/Province
Florida
ZIP/Postal Code
33306
Country
United States
Facility Name
Forest Investigative Site 006
City
Hallandale Beach
State/Province
Florida
ZIP/Postal Code
33009
Country
United States
Facility Name
Forest Investigative Site 044
City
Longwood
State/Province
Florida
ZIP/Postal Code
32779
Country
United States
Facility Name
Forest Investigative Site 001
City
Miami
State/Province
Florida
ZIP/Postal Code
33014
Country
United States
Facility Name
Forest Investigative Site 012
City
Miami
State/Province
Florida
ZIP/Postal Code
33014
Country
United States
Facility Name
Forest Investigative Site 032
City
Miami
State/Province
Florida
ZIP/Postal Code
33014
Country
United States
Facility Name
Forest Investigative Site 055
City
Miami
State/Province
Florida
ZIP/Postal Code
33014
Country
United States
Facility Name
Forest Investigative Site 045
City
Oviedo
State/Province
Florida
ZIP/Postal Code
32765
Country
United States
Facility Name
Forest Investigative Site 031
City
St. Petersburg
State/Province
Florida
ZIP/Postal Code
33709
Country
United States
Facility Name
Forest Investigative Site 009
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30084
Country
United States
Facility Name
Forest Investigative Site 007
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60611
Country
United States
Facility Name
Forest Investigative Site 004
City
Morton
State/Province
Illinois
ZIP/Postal Code
61550
Country
United States
Facility Name
Forest Investigative Site 072
City
Evansville
State/Province
Indiana
ZIP/Postal Code
47713
Country
United States
Facility Name
Forest Investigative Site 069
City
Newburgh
State/Province
Indiana
ZIP/Postal Code
47630
Country
United States
Facility Name
Forest Investigative Site 025
City
Augusta
State/Province
Kansas
ZIP/Postal Code
67010
Country
United States
Facility Name
Forest Investigative Site 029
City
Louisville
State/Province
Kentucky
ZIP/Postal Code
40213
Country
United States
Facility Name
Forest Investigative Site 068
City
Madisonville
State/Province
Kentucky
ZIP/Postal Code
42431
Country
United States
Facility Name
Forest Investigative Site 061
City
Metairie
State/Province
Louisiana
ZIP/Postal Code
70005
Country
United States
Facility Name
Forest Investigative Site 057
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70119
Country
United States
Facility Name
Forest Investigative Site 058
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70119
Country
United States
Facility Name
Forest Investigative Site 008
City
Lutherville
State/Province
Maryland
ZIP/Postal Code
21093
Country
United States
Facility Name
Forest Investigative Site 062
City
Fall River
State/Province
Massachusetts
ZIP/Postal Code
02702
Country
United States
Facility Name
Forest Investigative Site 075
City
Paw Paw
State/Province
Michigan
ZIP/Postal Code
49079
Country
United States
Facility Name
Forest Investigative Site 019
City
Brooklyn Center
State/Province
Minnesota
ZIP/Postal Code
55430
Country
United States
Facility Name
Forest Investigative Site 017
City
Chaska
State/Province
Minnesota
ZIP/Postal Code
55318
Country
United States
Facility Name
Forest Investigative Site 038
City
Belzoni
State/Province
Mississippi
ZIP/Postal Code
39038
Country
United States
Facility Name
Forest Investigative Site 035
City
Olive Branch
State/Province
Mississippi
ZIP/Postal Code
38654
Country
United States
Facility Name
Forest Investigative Site 023
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89101
Country
United States
Facility Name
Forest Investigative Site 048
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89101
Country
United States
Facility Name
Forest Investigative Site 052
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89101
Country
United States
Facility Name
Forest Investigative Site 014
City
Elizabeth
State/Province
New Jersey
ZIP/Postal Code
27609
Country
United States
Facility Name
Forest Investigative Site 051
City
Trenton
State/Province
New Jersey
ZIP/Postal Code
08611
Country
United States
Facility Name
Forest Investigative Site 003
City
Asheboro
State/Province
North Carolina
ZIP/Postal Code
27203
Country
United States
Facility Name
Forest Investigative Site 010
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28277
Country
United States
Facility Name
Forest Investigative Site 011
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27609
Country
United States
Facility Name
Forest Investigative Site 016
City
Raleigh
State/Province
North Carolina
ZIP/Postal Code
27609
Country
United States
Facility Name
Forest Investigative Site 005
City
Wilmington
State/Province
North Carolina
ZIP/Postal Code
28401
Country
United States
Facility Name
Forest Investigative Site 036
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27103
Country
United States
Facility Name
Forest Investigative Site 002
City
Columbus
State/Province
Ohio
ZIP/Postal Code
43213
Country
United States
Facility Name
Forest Investigative Site 050
City
Norman
State/Province
Oklahoma
ZIP/Postal Code
73069
Country
United States
Facility Name
Forest Investigative Site 030
City
Portland
State/Province
Oregon
ZIP/Postal Code
33709
Country
United States
Facility Name
Forest Investigative Site 056
City
Downingtown
State/Province
Pennsylvania
ZIP/Postal Code
19335
Country
United States
Facility Name
Forest Investigative Site 022
City
Pelzer
State/Province
South Carolina
ZIP/Postal Code
29669
Country
United States
Facility Name
Forest Investigative Site 053
City
Beaumont
State/Province
Texas
ZIP/Postal Code
77701
Country
United States
Facility Name
Forest Investigative Site 066
City
Boerne
State/Province
Texas
ZIP/Postal Code
78006
Country
United States
Facility Name
Forest Investigative Site 076
City
Corpus Christi
State/Province
Texas
ZIP/Postal Code
78404
Country
United States
Facility Name
Forest Investigative Site 037
City
Dallas
State/Province
Texas
ZIP/Postal Code
75234
Country
United States
Facility Name
Forest Investigative Site 043
City
Haltom City
State/Province
Texas
ZIP/Postal Code
84070
Country
United States
Facility Name
Forest Investigative Site 015
City
Houston
State/Province
Texas
ZIP/Postal Code
77081
Country
United States
Facility Name
Forest Investigative Site 026
City
Houston
State/Province
Texas
ZIP/Postal Code
77081
Country
United States
Facility Name
Forest Investigative Site 027
City
Houston
State/Province
Texas
ZIP/Postal Code
77081
Country
United States
Facility Name
Forest Investigative Site 074
City
Houston
State/Province
Texas
ZIP/Postal Code
77081
Country
United States
Facility Name
Forest Investigative Site 071
City
Orem
State/Province
Utah
ZIP/Postal Code
84058
Country
United States
Facility Name
Forest Investigative Site 042
City
Sandy
State/Province
Utah
ZIP/Postal Code
84070
Country
United States
Facility Name
Forest Investigative Site 063
City
Norfolk
State/Province
Virginia
ZIP/Postal Code
23502
Country
United States
Facility Name
Forest Investigative Site 064
City
Norfolk
State/Province
Virginia
ZIP/Postal Code
23502
Country
United States
Facility Name
Forest Investigative Site 046
City
Port Orchard
State/Province
Washington
ZIP/Postal Code
98366
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years)
We'll reach out to this number within 24 hrs